全文获取类型
收费全文 | 1475篇 |
免费 | 57篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 15篇 |
妇产科学 | 6篇 |
基础医学 | 137篇 |
口腔科学 | 34篇 |
临床医学 | 116篇 |
内科学 | 445篇 |
皮肤病学 | 57篇 |
神经病学 | 173篇 |
特种医学 | 44篇 |
外科学 | 175篇 |
综合类 | 3篇 |
预防医学 | 26篇 |
眼科学 | 71篇 |
药学 | 59篇 |
中国医学 | 1篇 |
肿瘤学 | 163篇 |
出版年
2023年 | 6篇 |
2022年 | 11篇 |
2021年 | 28篇 |
2020年 | 13篇 |
2019年 | 30篇 |
2018年 | 26篇 |
2017年 | 24篇 |
2016年 | 33篇 |
2015年 | 26篇 |
2014年 | 45篇 |
2013年 | 58篇 |
2012年 | 81篇 |
2011年 | 102篇 |
2010年 | 61篇 |
2009年 | 52篇 |
2008年 | 72篇 |
2007年 | 135篇 |
2006年 | 97篇 |
2005年 | 107篇 |
2004年 | 96篇 |
2003年 | 92篇 |
2002年 | 113篇 |
2001年 | 28篇 |
2000年 | 26篇 |
1999年 | 22篇 |
1998年 | 25篇 |
1997年 | 19篇 |
1996年 | 13篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 9篇 |
1992年 | 14篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1970年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有1540条查询结果,搜索用时 312 毫秒
51.
Shingo Hatakeyama Shintaro Narita Masahiro Takahashi Toshihiko Sakurai Sadafumi Kawamura Senji Hoshi Masanori Ishida Toshiaki Kawaguchi Shigeto Ishidoya Jiro Shimoda Hiromi Sato Itsuto Hamano Teppei Okamoto Koji Mitsuzuka Akihiro Ito Norihiko Tsuchiya Yoichi Arai Tomonori Habuchi Chikara Ohyama 《International journal of urology》2020,27(7):610-617
52.
53.
Hideharu Hagiya Keigo Kimura Hideo Okuno Shigeto Hamaguchi Daiichi Morii Hisao Yoshida Tomomi Mitsui Isao Nishi Kazunori Tomono 《Journal of infection and chemotherapy》2019,25(11):906-908
Corynebacterium striatum, generally considered an opportunistic organism in humans, has recently been known to develop high-level daptomycin resistance (HLDR) shortly after drug exposure. To date, however, only several such clinical isolates have been described in the literature and clinical background of the resistant pathogen remains to be elucidated. Here, we report a case involving a C. striatum strain with HLDR harboring novel nucleotide mutations, together with a review of the relevant literature. To the best of our knowledge, this is the first well-investigated clinical report from Japan including a genetic investigation. Considering the rapid emergence of HLDR C. striatum in vitro experiment, there could be a number of underreporting cases. Scrupulous attention is required when administering daptomycin for the treatment of C. striatum infections, even if the organism has initially exhibited susceptibility. 相似文献
54.
Tokano Y Morimoto S Amano H Kawanishi T Yano T Tomyo M Sugawara M Kobayashi S Tsuda H Takasaki Y Hashimoto H 《Modern rheumatology / the Japan Rheumatism Association》2005,15(4):275-282
The relationship between clinical manifestations and prognosis was examined and evaluated among systemic lupus erythematosus (SLE) patients. A total of 542 patients with SLE were selected and divided into nine groups according to their main clinical manifestation at the time of initial diagnosis. The relationship between these clinical manifestations and long-term prognosis was evaluated in respect to the survival, remission, relapse rates, the development of a new clinical manifestation, and/or damage index. Patients with neuropsychiatric SLE (NPSLE), accompanied with acute confusional state/seizure disorder, cerebral vascular disease, or pneumonitis had poor survival rates with cause of death related to their major organ involvement. Patients with nephropathy or leukopenia had lower remission rates, and an increase in relapse rates was frequently recognized in patients with pneumonitis. Body damage (damage index) was higher in patients with lupus psychosis, pneumonitis, and/or arthritis. The translation of the main manifestations after diagnosis was confirmed in 64 patients (11.8%), and often observed in patients with autoimmune hemolytic anemia and arthritis. The majority of these manifestations were nephropathy, NPSLE, thrombocytopenia, and pneumonitis, and the prognosis of patients with nephropathy and thrombocytopenia as a new main manifestation had a poor outcome. The results of long-term prognosis in SLE greatly differed with respect to the initial clinical manifestation at the time of diagnosis. 相似文献
55.
Shinpei Yoshimura Yasumasa Okamoto Keiichi Onoda Miki Matsunaga Go Okada Yoshihiko Kunisato Atsuo Yoshino Kazutaka Ueda Shin-ichi Suzuki Shigeto Yamawaki 《Social cognitive and affective neuroscience》2014,9(4):487-493
Cognitive behavioral therapy (CBT), an effective treatment for depression, targets self-referential processing of emotional stimuli. We examined the effects of CBT on brain functioning during self-referential processing in depressive patients using functional magnetic resonance imaging (fMRI). Depressive patients (n = 23) and healthy participants (n = 15) underwent fMRI scans during a self-referential task using emotional trait words. The depressive patients had fMRI scans before and after completing a total of 12 weekly sessions of group CBT for depression, whereas the healthy participants underwent fMRI scans 12 weeks apart with no intervention. Before undergoing CBT, the depressive patients showed hyperactivity in the medial prefrontal cortex (MPFC) during self-referential processing of negative words. Following CBT, MPFC and ventral anterior cingulate cortex (vACC) activity during self-referential processing among depressive patients was increased for positive stimuli, whereas it was decreased for negative stimuli. Improvements in depressive symptoms were negatively correlated with vACC activity during self-referential processing of negative stimuli. These results suggest that CBT-related improvements in depressive symptoms are associated with changes in MPFC and vACC activation during self-referential processing of emotional stimuli. 相似文献
56.
Megumi Hashimoto Kazuko Igari Soshi Hanawa Ayumi Ito Atsushi Takahashi Naoko Ishida Shigeto Koyama Takahiro Ono Keiichi Sasaki 《Dysphagia》2014,29(4):509-518
In individuals with Down syndrome, hypotonicity of the tongue and an underdeveloped maxilla may lead to poor oral motor coordination, which adversely affects the oral phase of swallowing. This study aimed to evaluate the characteristics of pressure produced by the tongue against the hard palate during swallowing in individuals with Down syndrome. In addition, the relationship between tongue pressure and palatal morphology was examined. We studied nine adults with Down syndrome and ten healthy adults as controls. Tongue pressure while swallowing 5 mL water was recorded by a sensor sheet system with five measuring points attached to the hard palate. Palatal length, depth, width, curvature, and slope were measured by three-dimensional digital maxillary imaging. The order of onset of tongue pressure on the median line of the hard palate was the same in all participants, except for three with Down syndrome. The duration and maximal magnitude of tongue pressure on the median line in nine participants with Down syndrome were significantly shorter and lower than those of controls. In participants with Down syndrome, significant positive correlations were observed between the duration of tongue pressure at the mid-median part of the hard palate and palatal depth and width, and between the duration and maximal magnitude of tongue pressure at the posterior-median part and palatal length. These findings suggest that impaired tongue activity, poor tongue control, and constrained tongue motion due to a short and narrow palate contribute to swallowing difficulty in individuals with Down syndrome. 相似文献
57.
Maho Suzukawa Nobuharu Ohshima Hiroyuki Tashimo Isao Asari Nobuyuki Kobayashi Shunsuke Shoji Shigeto Tohma Ken Ohta 《Internal medicine (Tokyo, Japan)》2020,59(22):2849
Objective Mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, is effective for treating eosinophilic severe asthma. However, there is a need for more biomarkers that can predict the patient response to mepolizumab before starting therapy. This study aimed to identify a new biomarker in the serum that is able to accurately predict the responsiveness to mepolizumab. Methods This study enrolled 11 patients who had all been diagnosed with severe eosinophilic asthma and were then administered mepolizumab every 4 weeks for at least 4 months. Blood samples were collected, and pulmonary function tests and questionnaires were administered at baseline and after 4, 8 and 16 weeks of treatment. The response to mepolizumab was then assessed based on the difference in the Asthma Quality of Life Questionnaire (AQLQ) score after 16 weeks of mepolizumab therapy compared with that at baseline. Patients with an increase in the AQLQ score of more than 0.5 were defined as responders. The cytokine levels in the blood were measured by LUMINEX 200 and ELISA. Results There were 6 responders and 5 non-responders. The responders showed a significantly lower serum level of chemokine (C-C motif) ligand 4/macrophage inflammatory protein-1β (CCL4/MIP-1β) at baseline compared to the non-responders. Receiver operating characteristic curves to distinguish responders from non-responders using the baseline serum CCL4/MIP-1β level showed a good area under the curve of 0.9. The non-responders showed a significant increase in the level of CCL4/MIP-1β after 4 weeks compared to the baseline. Conclusion A low baseline serum CCL4/MIP-1β level may be useful for predicting a good mepolizumab response in severe eosinophilic asthma. 相似文献
58.
Microarray and FISH‐based genotype–phenotype analysis of 22 Japanese patients with Wolf–Hirschhorn syndrome
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kenji Shimizu Keiko Wakui Tomoki Kosho Nobuhiko Okamoto Seiji Mizuno Kazuya Itomi Shigeto Hattori Kimio Nishio Osamu Samura Yoshiyuki Kobayashi Yuko Kako Takashi Arai Tsutomu Oh‐ishi Hiroshi Kawame Yoko Narumi Hirofumi Ohashi Yoshimitsu Fukushima 《American journal of medical genetics. Part A》2014,164(3):597-609
59.
Yuki Matsumoto Mikiko Kobayashi Kunihiko Shingu Ayako Tateishi Maki Ohya Kenji Sano Tatsuya Negishi Shohei Shigeto Tatsuya Kobayashi Yosuke Hara Yukinari Kakizawa Hiroyuki Kanno 《Neuropathology》2020,40(5):507-514
Pleomorphic xanthoastrocytomas (PXAs) are rare low-grade astrocytic tumors that typically present as superficial nodular cystic tumors of the cerebrum attached to the leptomeninx. Histologically, they are pleomorphic, hypercellular glial neoplasms. Despite the presence of microscopic pleomorphism, patients’ postoperative prognosis is generally good. Anaplastic PXAs (APXAs) have a high mitotic index and patients with APXAs have a worse prognosis than patients with PXAs. Here, we report an autopsy case of APXA initially diagnosed as PXA. After gross total resection, the tumor recurred and was diagnosed as an APXA; thereafter, the patient died. An autopsy revealed that the tumor had relapsed at the primary site and had spread to the leptomeningeal space while concurrently invading the cerebrum including the periventricular area forming multifocal lesions. The histological findings of the autopsy were similar to those for epithelioid glioblastoma (EGBM) and small cell glioblastoma (SCGBM). In particular, the periventricular area with multifocal lesions was composed of SCGBM-like cells. It has been shown that multifocal lesions are frequently identified in patients with SCGBM. This is the first histopathologically confirmed case of APXA-related tumor presenting with periventricular extension and multifocal lesion formation. The periventricular extension might be a feature of PXAs and APXAs. However, suspected periventricular spread on imaging in past cases of PXAs and APXAs might instead represent the malignant transformation of these tumors to glioblastoma-like high-grade tumors, which often show SCGBM-like histological patterns. 相似文献